<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To determine the expression and function of the c-kit receptor in bone marrow mononuclear cells (BMMNC) of patients with <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Direct immunofluorescence assay and reverse transcriptase-polymerase chain reaction (RT-PCR) were used to detect c-kit protein and c-kit <z:chebi fb="2" ids="33699">mRNA</z:chebi> expressions in the BMMNC of 29 MDS patients and 10 <z:mpath ids='MPATH_458'>normal</z:mpath> controls </plain></SENT>
<SENT sid="2" pm="."><plain>Cell culture was used to detect the function of the c-kit receptor </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: c-kit protein expression in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> group was significantly higher than that in the control group (8.58% +/- 5.28% vs 3.04% +/- 1.49%, P &lt; 0.05) </plain></SENT>
<SENT sid="4" pm="."><plain>c-kit protein expression in the <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> (RA) group was significantly lower than that in the RA with an excess of blasts (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>)/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> in transformation (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>-t) group (5.12% +/- 2.13% vs 10.01% +/- 5.07%, P &lt; 0.05) </plain></SENT>
<SENT sid="5" pm="."><plain>The rate of c-kit protein expression was 32.43% in <z:hpo ids='HP_0004808'>acute myeloblastic leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) cases transformed from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> (t-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) </plain></SENT>
<SENT sid="6" pm="."><plain>c-kit <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> group was correlated with c-kit protein expression </plain></SENT>
<SENT sid="7" pm="."><plain>Interleukin-3 (IL-3) and erythropoietin (Epo), with or without stem cell factor (SCF), upregulated c-kit protein and its <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression </plain></SENT>
<SENT sid="8" pm="."><plain>In the presence of IL-3 and Epo, SCF showed significant stimulating effects on the formation of CFU-GM and BFU-E in semi-solid cultures of <z:mpath ids='MPATH_458'>normal</z:mpath> BMMNC, but had no effects on those of the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: The protein and <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression of the c-kit receptor in the BMMNC of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients were higher than those of <z:mpath ids='MPATH_458'>normal</z:mpath> controls, and the function of this receptor in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> BMMNC was abnormal </plain></SENT>
</text></document>